Groupama Asset Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$618K Sell
3,918
-2,250
-36% -$375K 0.01% 290
2026
Q1
$1.29M Sell
6,168
-83
-1% -$20.9K 0.02% 182
2025
Q4
$1.78M Sell
6,251
-115
-2% -$36K 0.03% 178
2025
Q3
$1.97M Sell
6,366
-1,287
-17% -$403K 0.03% 171
2025
Q2
$2.4M Buy
7,653
+3,894
+104% +$1.12M 0.04% 166
2025
Q1
$2.29M Buy
+3,759
New +$1.02M 0.05% 170
2024
Q4
– Sell
-517
Closed -$130K – 242
2024
Q3
$1.1M Sell
517
-2,888
-85% -$593K 0.03% 248
2024
Q2
$687K Buy
3,405
+2,856
+520% +$515K 0.01% 340
2024
Q1
$94.1K Buy
549
+54
+11% +$10.1K ﹤0.01% 456
2023
Q4
$107K Buy
+495
New +$84.9K ﹤0.01% 397

Other funds holding PODD

Groupama Asset Management's PODD Position: Q2 2026 in Review

Groupama Asset Management reduced its Insulet (PODD) stake by 36% in Q2 2026, selling an estimated $375K and leaving 3,918 shares worth $618K. The position accounts for 0.01% of the portfolio, ranked #290.

Groupama Asset Management first reported a position in PODD in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.4M in Q2 2025. 731 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Groupama Asset Management held 3,918 shares of Insulet worth $618K as of Q2 2026.
  • Groupama Asset Management sold 2,250 Insulet shares in Q2 2026, an estimated $375K.
  • Insulet made up 0.01% of Groupama Asset Management's portfolio in Q2 2026, its #290 holding.
  • Groupama Asset Management first reported a position in Insulet in Q4 2023 and has held it in 10 quarters since.
  • Groupama Asset Management's Insulet position peaked at $2.4M in Q2 2025.
  • 731 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.